About Aspen Neuroscience
Aspen Neuroscience is a company based in San Diego (United States) founded in 2018 by Andres Bratt-Leal.. Aspen Neuroscience has raised $339 million across 5 funding rounds from investors including SVB, ARE and Mirae Asset. Aspen Neuroscience offers products and services including ANPD001. Aspen Neuroscience operates in a competitive market with competitors including BridgeBio, Spark Therapeutics, Alnylam, ATAI and Insitro, among others.
- Headquarter San Diego, United States
- Founders Andres Bratt-Leal
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$339 M (USD)
in 5 rounds
-
Latest Funding Round
$115 M (USD), Series C
Nov 20, 2025
-
Investors
SVB
& 20 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Aspen Neuroscience
Aspen Neuroscience offers a comprehensive portfolio of products and services, including ANPD001. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Autologous iPSC-derived neuron therapy for Parkinson's disease treatment.
Unlock access to complete
Unlock access to complete
Funding Insights of Aspen Neuroscience
Aspen Neuroscience has successfully raised a total of $339M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $115 million completed in November 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series C — $115.0M
-
First Round
First Round
(12 Dec 2019)
- Investors Count 21
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2025 | Amount | Series C - Aspen Neuroscience | Valuation | Orbimed , Arch Venture Partners | |
| Dec, 2022 | Amount | Debt – Conventional - Aspen Neuroscience | Valuation |
investors |
|
| May, 2022 | Amount | Series B - Aspen Neuroscience | Valuation | Google Ventures , LYFE Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Aspen Neuroscience
Aspen Neuroscience has secured backing from 21 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include SVB, ARE and Mirae Asset. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Corporate backed venture capital fund investing in multiple sectors
|
Founded Year | Domain | Location | |
|
LYFE Capital is recognized as a premier healthcare investment platform.
|
Founded Year | Domain | Location | |
|
Government-backed investments are directed toward healthcare, fintech, and various sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Aspen Neuroscience
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Aspen Neuroscience
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Aspen Neuroscience Comparisons
Competitors of Aspen Neuroscience
Aspen Neuroscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BridgeBio, Spark Therapeutics, Alnylam, ATAI and Insitro, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
RNA interference-based therapeutics are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| domain | founded_year | HQ Location |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| domain | founded_year | HQ Location |
Therapeutics for rare and ultra-rare metabolic diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Aspen Neuroscience
Frequently Asked Questions about Aspen Neuroscience
When was Aspen Neuroscience founded?
Aspen Neuroscience was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Where is Aspen Neuroscience located?
Aspen Neuroscience is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Is Aspen Neuroscience a funded company?
Aspen Neuroscience is a funded company, having raised a total of $339M across 5 funding rounds to date. The company's 1st funding round was a Series B of $147.5M, raised on Dec 12, 2019.
What does Aspen Neuroscience do?
Aspen Neuroscience was founded in 2018 and is based in San Diego, United States. Operations focus on the biotechnology sector, specifically regenerative medicine. Personalized pluripotent stem cell therapies are developed, including dopaminergic neurons targeted at Parkinsons disease and other neurological conditions. Genetic-based quality control is maintained to prevent cell mutations in therapeutic applications.
Who are the top competitors of Aspen Neuroscience?
Aspen Neuroscience's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.
What products or services does Aspen Neuroscience offer?
Aspen Neuroscience offers ANPD001.
Who are Aspen Neuroscience's investors?
Aspen Neuroscience has 21 investors. Key investors include SVB, ARE, Mirae Asset, Orbimed, and Arch Venture Partners.